Vontobel Holding
BLFS icon

Vontobel Holding’s BioLife Solutions BLFS Stock Holding History

Vontobel Holding’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,750
Closed -$523K – 1166
2021
Q2 		$523K Buy
11,750
+1,250
+12% +$44K ﹤0.01% 749
2021
Q1 		$378K Buy
+10,500
New +$415K ﹤0.01% 736

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Vontobel Holding's BLFS Position: Q3 2021 in Review

Vontobel Holding sold out of BioLife Solutions (BLFS) in Q3 2021, closing a stake of 11,750 shares — an estimated $523K sold.

Vontobel Holding first reported a position in BLFS in Q1 2021 and held it in 2 quarters. The position peaked at $523K in Q2 2021. 165 funds tracked by Wall St. Rank hold BLFS as of Q3 2021.

  • Vontobel Holding reported no remaining BioLife Solutions position as of Q3 2021 after selling out during the quarter.
  • Vontobel Holding sold 11,750 BioLife Solutions shares in Q3 2021, an estimated $523K.
  • Vontobel Holding first reported a position in BioLife Solutions in Q1 2021 and held it in 2 quarters.
  • Vontobel Holding's BioLife Solutions position peaked at $523K in Q2 2021.
  • 165 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2021.

Based on Vontobel Holding's 13F filing for Q3 2021, filed 29 Oct 2021.